Guardian Pharmacy Services (GRDN) Income from Continuing Operations (2023 - 2026)

Guardian Pharmacy Services has disclosed Income from Continuing Operations across 4 years of filings, most recently posting 13544000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 13544000.0, up 46.06% year-over-year; the trailing twelve-month figure through Mar 2026 was 53229000.0 (up 177.31% YoY), and the FY2025 annual result was 48958000.0, up 168.92% from the prior year.
• Income from Continuing Operations came in at 13544000.0 for Q1 2026 at Guardian Pharmacy Services, down from 21265000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 21265000.0 in Q4 2025 to a low of 105817000.0 in Q3 2024.
• The 4-year median for Income from Continuing Operations is 9593000.0 (2025), against an average of 87909.09.
• Across the five-year window, Income from Continuing Operations sank 1412.75% in 2024 and soared 109.07% in 2025, its largest moves.
• Guardian Pharmacy Services' Income from Continuing Operations stood at 14559000.0 in 2023, then declined by 18.67% to 11841000.0 in 2024, then jumped by 79.59% to 21265000.0 in 2025, then tumbled by 36.31% to 13544000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 13544000.0 (Q1 2026), 21265000.0 (Q4 2025), and 9593000.0 (Q3 2025), per Business Quant data.